ERBB2 and breast cancer: Recently, breast carcinomas have been classified into the following clinicopathological subtypes based on molecular profiling: luminal, human epidermal growth factor receptor (HER2) overexpressing, normal-like, and basal-like breast cancers (BLBCs) [1].